-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_disposition-comments.pdf
July 03, 2012 - How do available panels predict the risk of prostate cancer when
substituted for, or added to, PSA based … benefit to a
patient for using a particular decision rule to opt for a prostate biopsy or
perhaps PSA … screening, specifically, by choosing a threshold risk and
deciding to undergo biopsy or PSA screening
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
July 01, 2012 - Prostate-specific antigen (PSA) was approved by the US
Food and Drug Administration in 1986 for monitoring … screening asymptomatic men).14 A meta-
analysis of seven randomized controlled trials of screening
using PSA … How do SNP-based strategies (alone or in
combination with PSA) compare with current practice? … cancer mortality for any of the panels,47,55,59 and no increase
in the AUC of a model based on age, PSA … Meta-analysis
finds screening for prostate cancer with PSA does not
reduce prostate cancer-related
-
effectivehealthcare-admin.ahrq.gov/products/methods-guidance-applicability/methods
May 01, 2020 - Cancer registries in the United States indicate that most localized cancers are detected by PSA testing … A2 (SPCG-4) 1989-1999, Sweden
Mean age 65
78% T2; 60% Gleason 6 or lower
Few detected by PSA … 1967-1975, Denmark
Mean age 64.2
46.5% Stage 2; 86.5% Gleason 6 or lower
None detected by PSA … to current practices due to the evolving techniques in both stage and grade
classification since PSA … the largest group of prostate cancer patients in the United States, those with cancers detected by PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-applicability_methods.pdf
January 01, 2011 - Cancer registries in the United States indicate that most localized
cancers are detected by PSA testing … Few detected by
PSA
Radical
prostatectomy at
18 centers;
standard current
protocol
Watchful … None
detected by
PSA. … to current
practices due to the
evolving techniques in
both stage and grade
classification since PSA … the largest group of prostate cancer patients
in the United States, those with cancers detected by PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/methods_guide_atkins.pdf
January 01, 2011 - Cancer registries in the United States indicate that most localized
cancers are detected by PSA testing … Few detected by
PSA
Radical
prostatectomy at
18 centers;
standard current
protocol
Watchful … None
detected by
PSA. … to current
practices due to the
evolving techniques in
both stage and grade
classification since PSA … the largest group of prostate cancer patients
in the United States, those with cancers detected by PSA
-
effectivehealthcare-admin.ahrq.gov/products/rheumatoid-arthritis-2007/research
December 01, 2019 - biologic DMARDs in the treatment of patients with either rheumatoid arthritis (RA) or psoriatic arthritis (PsA
-
effectivehealthcare-admin.ahrq.gov/health-topics/prostate-cancer
September 17, 2020 - You may also get a blood test for prostate-specific antigen (PSA).
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/cer-230-prostate-cancer-comments.pdf
September 17, 2020 - • The reviewers repeatedly emphasized the distinction between mostly PSA-based
active monitoring
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/prostate-cancer-therapies-protocol_amended110619.pdf
November 02, 2019 - , or ablated.3, 4 Instead, tumors are monitored through
surveillance of prostate specific antigen (PSA … patient characteristics (e.g., age, ethnicity, comorbidities, preferences),
tumor characteristics (e.g., PSA … 1) Baseline PSA
2) Gleason score
3) Tumor index scores (e.g., Cancer of the Prostate Risk Assessment … hormone-releasing hormone
MRI= magnetic resonance imaging
NCCN= National Comprehensive Cancer Network
PSA
-
effectivehealthcare-admin.ahrq.gov/products/prostate-cancer-therapies/protocol
March 01, 2020 - or ablated. 3 , 4 Instead, tumors are monitored through surveillance of prostate specific antigen (PSA … patient characteristics (e.g., age, ethnicity, comorbidities, preferences), tumor characteristics (e.g., PSA … Baseline PSA
Gleason score
Tumor index scores (e.g., Cancer of the Prostate Risk Assessment Score … hormone-releasing hormone
MRI= magnetic resonance imaging
NCCN= National Comprehensive Cancer Network
PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypofractionated-radiation-therapy-protocol.pdf
April 17, 2024 - These include reduced access to prostate-specific antigen-based (PSA) screening and high-
quality prostate … Racial and Ethnic Variation in PSA Testing and Prostate
Cancer Incidence Following the 2012 USPSTF Recommendation … treated
by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA … recurrence-free survival: The length of time after treatment during which a patient has no
evidence of rising PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/braddock.pdf
January 01, 2011 - decision-‐making
o Fewer people remaining
undecided
o Fewer patients choosing
major surgery, PSA
-
effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/can-screening-among-the-general-adult-male-population-for-elevated-pca3-also-known-as-dd3-gene-expression-to-identify-those-at-risk-for-prostate-cancer-who-may-be-candidates-for-prostate-biopsy-reduce-morbidity-and-mortality
November 01, 2017 - commercially available PCA3 expression assays for prostate cancer screening tests vs. screening by PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/moyer_eccs2012.pdf
January 01, 2012 - of Pediatrics
Baylor College of Medicine,
Houston,
TX
Slide 2: A Recent Controversy
“Those PSA
-
effectivehealthcare-admin.ahrq.gov/products/hypofractionated-radiation-therapy/protocol
December 01, 2024 - These include reduced access to prostate-specific antigen-based (PSA) screening and high-quality prostate … Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation … treated by external beam radiation therapy alone using a post-treatment repeated-measures model for PSA … recurrence-free survival : The length of time after treatment during which a patient has no evidence of rising PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/psoriasis-chronic_executive.pdf
November 01, 2012 - However, there was insufficient evidence to
grade HRQoL, BSA, PASI, PGA, psoriatic arthritis (PsA) … Two observational studies25,27 evaluated the impact of
weight on PGA, the impact of a history of PsA … on plaque
psoriasis or PsA pain, and the impact of prior exposure to
a biologic agent on PASI. … Index
PCS Physical Component Summary (part
of SF-36)
PGA Physician’s Global Assessment
PsA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/schwitzer_eccs2012.pdf
July 23, 2012 - emeritus of family medicine at Brown
University School of Medicine, tells his physician not to order a PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/communicating_risk_media_wilkes.ppt
April 01, 2006 - surgical implants when a similar operation without implants works better;
Doctors order diagnostic tests (PSA
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cancer-decision-support-tools_disposition-comments.pdf
December 23, 2014 - concerned
the review missed 2 previous reviews which each found decision aids
decreased uptake of PSA … TEP Reviewer #4 Results P. 23 Cochrane systematic review of decision aids has subgruop
analysis on PSA … We did not undertake a subgroup analysis
specific to PSA testing.
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-grading_methods.pdf
July 01, 2012 - some tests that have continuous outcomes
and possibly multiple cutoffs [e.g., gene expression,
serum PSA … some tests that have continuous outcomes and possibly multiple
cutoffs (e.g., gene expression, serum PSA